Ładuje się......
Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome
Tumor lysis syndrome (TLS) is a life-threatening oncological emergency, in which control of serum uric acid (S-UA) levels is important. S-UA-lowering efficacy of a new xanthine oxidase inhibitor, febuxostat, was retrospectively evaluated in seven patients with hematological malignancies who were at...
Zapisane w:
| Główni autorzy: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
D.A. Spandidos
2014
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4156226/ https://ncbi.nlm.nih.gov/pubmed/25202361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.2394 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|